The email every lab director dreads.
You open the proficiency testing results, expecting routine passes like always. Your lab runs excellent quality control. Your staff is well trained. Your equipment is maintained meticulously.-
Then you see it: “Unacceptable Performance.”
Your stomach drops. This isn’t just a bad result. Under CLIA, this is a regulatory event that triggers mandatory investigation, corrective action, and potential sanctions.
And here’s what makes PT failures so frustrating: they often don’t reflect actual laboratory problems. A single moment of attention, a transcription error, or a misunderstanding of the sample can cause a failure that suggests your lab can’t perform basic testing.
But CLIA doesn’t care about excuses. The regulation is clear: proficiency testing failures require immediate, documented response.
If you run a CLIA-certified laboratory, understanding PT requirements isn’t optional. It’s survival.
Let’s break down what constitutes a PT failure, what CLIA requires when it happens, and most importantly, how to prevent failures before they occur.
What Is Proficiency Testing (And Why CLIA Takes It So Seriously)
Proficiency testing is how CLIA verifies your laboratory and can accurately test patient specimens.
Here’s how it works:
Three times per year (or twice, depending on the analyte), an approved PT provider sends your lab unknown samples. You test them exactly like patient specimens, using your routine methods and equipment. You report results to the PT provider. The provider scores your results against target values and acceptable ranges.
Think of PT as a report card for your lab’s competence.
CLIA uses PT to answer one critical question: Can this laboratory accurately identify what’s in a specimen?
If you can’t correctly analyze a PT sample, CLIA assumes you can’t correctly analyze patient samples either. That’s why PT failures trigger such serious consequences.
What Actually Constitutes a PT Failure Under CLIA
Not all “unacceptable” PT results are created equal. CLIA defines failures based on the analysis and testing specialty.
The 80% Rule (Most Specialties)
For most testing categories, you fail if you miss more than 2 out of 10 PT challenges (or 1 out of 5 challenges for certain analytes) within a single testing event or over two consecutive events.
Example: In Chemistry, you receive 5 glucose samples per PT event. If you get 2 wrong in one event, that’s a PT failure for glucose.
Unsuccessful Participation
You also fail PT if you don’t participate properly:
- Not enrolling in a CLIA-approved PT program when required
- Testing PT samples but not reporting results on time
- Referring PT samples to another lab for testing
- Failing to test all required analytes
Quick reminder: Under CLIA, PT samples must be tested by your laboratory using your routine procedures. Sending them to a reference lab is considered fraud.
Consequence Categories
CLIA categorizes PT failures into two types:
Unsuccessful PT Performance: Missing too many challenges for a specific analyte (like glucose or hemoglobin).
Unsatisfactory PT Performance: Failing PT for an entire specialty or subspecialty (like all Clinical Chemistry or Hematology).
What CLIA Requires When PT Fails
The moment you receive an unacceptable PT result, the clock starts ticking. CLIA requires specific actions, and they must be documented.
Immediate Requirements (Within 30 Days)
1. Stop Reporting Patient Results (Sometimes)
If your PT failure indicates a systemic problem, you may need to immediately stop testing patient samples for that analyte until the problem is identified and corrected.
CLIA gives you some discretion here, but if the failure suggests your results are clinically unreliable, continuing to test patients is a patient safety issue.
2. Investigate the Cause
You must conduct a root cause analysis to determine why the PT failed.
This isn’t optional. CLIA regulation 42 CFR 493.1407(e)(12) specifically requires laboratories to “evaluate the effectiveness of corrective action taken to resolve problems and ensure that corrective action has been taken and is effective.”
What CLIA expects:
- Document exactly what went wrong
- Identify whether it was an isolated incident or systemic problem
- Determine if the issue could affect patient testing
- Review related patient results if indicated
Common root causes:
Analytical errors such as instrument malfunction, reagent failure, calibration drift, or contamination.
Pre-analytical errors like specimen mix-up, incorrect sample preparation, or failure to follow PT instructions.
Post-analytical errors include transcription mistakes, unit conversion errors, or clerical reporting errors.
Procedural failures such as not following manufacturer’s instructions, skipping quality control, or using incorrect calculation formulas.
3. Implement Corrective Action
Identifying the problem isn’t enough. You must fix it and prove the fix worked.
Effective corrective action includes:
Immediate fix (repair equipment, replace reagent, retrain staff).
Preventive measures (update procedures, add quality control checks, implement new monitoring).
Verification that the fix worked (retest PT sample, if possible, run additional QC, monitor patient results).
CLIA will ask: “How do you know this won’t happen again?”
Your documentation must answer that question.
4. Document Everything
CLIA operates on one principle: If it’s not documented, it didn’t happen.
You must create a written record including:
- Date PT failure was identified
- Description of what failed and why
- Investigation process and findings
- Corrective actions taken
- Verification that corrective action was effective
- Date corrective action was completed
Pro tip: Create a standardized PT failure investigation form. When a failure occurs, you’ll have a template ensuring you document everything CLIA expects.
Ongoing Requirements
Monitor Effectiveness
After implementing corrective action, you must monitor to ensure the problem is fixed.
This might include running additional quality control samples, reviewing patient results for that analyte, or retesting the PT sample (if your PT provider allows it).
Report to CLIA (If Required)
For some PT failures, your PT provider automatically reports results to CMS (the agency overseeing CLIA). But if your failure leads to suspension of testing for an analyte, you must notify CLIA directly.
The Consequences of PT Failure (And Why Prevention Matters)
PT failures aren’t just embarrassing. They’re expensive and operationally disruptive.
Immediate Consequences
Testing Restrictions
Depending on severity, you may need to stop performing the failed test until you’ve proven the problem is fixed. For high-volume tests, this means referring specimens out (lost revenue, delayed results for patients).
Required Remediation
You must investigate, correct, and document. This takes staff time, potentially outside consultant time, and creates operational disruption.
Increased Scrutiny
Once you’ve failed PT, CLIA surveyors pay closer attention during your next inspection. Expect deeper dives into your quality systems.
Escalating Sanctions
If PT problems continue, CLIA can impose progressively severe sanctions:
Directed plan of correction: CLIA tells you exactly what you must fix and how.
State onsite monitoring: A surveyor visits to observe your operations and verify compliance.
Civil monetary penalties: Fines ranging from $3,186 to $15,931 per violation per day.
Suspension or revocation of your CLIA certificate: You can no longer perform testing. This can effectively shut down your laboratory.
Reputational Damage
Even if CLIA doesn’t sanction you heavily, PT failures damage relationships with ordering physicians, hospitals, and patients. In competitive markets, word spreads quickly.
Bottom line: Prevention is far cheaper than remediation.
Why Smart Labs Still Fail PT
PT failures aren’t just embarrassing. They’re expensive and operationally disruptive.
1. Treating PT Samples Differently Than Patient Samples
Some labs unconsciously give PT samples “special treatment,” like running extra quality control, using different reagent lots, or having the most experienced tech perform the testing.
The problem: This violates CLIA’s requirement to test PT samples using routine procedures. If you fail PT while using special procedures, CLIA knows your routine testing is even worse.
The fix: Treat PT samples exactly like patient samples. Same workflow, same techs, same procedures.
2. Not Reading PT Instructions Carefully
PT providers include specific instructions with each shipment. Not reading them carefully causes failures.
Common mistakes:
- Failing to reconstitute lyophilized samples properly
- Using wrong specimen type (testing serum when plasma is required)
- Not allowing samples to reach room temperature before testing
- Missing special handling instructions
Real scenario: A lab consistently failed microbiology PT. Investigation revealed they were incubating cultures for 24 hours when PT instructions specified 48 hours. Once they followed instructions correctly, failures stopped.
3. Transcription and Reporting Errors
You perform the test perfectly, but report the result incorrectly.
Examples:
- Transposing digits (reporting 145 instead of 154)
- Wrong units (reporting mg/dL instead of g/dL)
- Decimal point errors (12.5 reported as 125)
- Copying results to the wrong line on the answer sheet
The fix: Implement a verification step. Have a second person double-check all PT results before submission.
4. Calibration Drift
Your instrument has been drifting slightly out of calibration, but daily QC still passes because it’s within acceptable limits. PT samples are at the edges of the analytical range, and the drift causes failure.
The lesson: PT often catches problems that routine QC misses because PT challenges your entire analytical range.
The fix: Don’t just run QC at medical decision points. Periodically verify performance across your full analytical range.
5. Reagent or Lot Changes
You changed reagent lots shortly before PT testing. The new lot performs slightly differently, and you didn’t verify it adequately before testing PT samples.
CLIA requirement: When you change reagent lots, you must verify that the new lot performs equivalent to the old lot.
The fix: Never introduce new reagents, calibrators, or controls immediately before PT testing without thorough verification.
6. Complacency
Your lab has passed PT for years. Staff assume PT samples are routine and doesn’t give them proper attention.
One moment of distraction (interrupted during testing, rushed because of high workload, assumed a result without double-checking) can cause failure.
The fix: Treat every PT event with the seriousness it deserves. Create a checklist, designate responsibility clearly, and build in verification steps.
How to Prevent PT Failures Before They Happen
The best PT failure response is the one you never need to write. Here’s how to build a PT program that consistently succeeds:
Step 1: Establish a PT Protocol
Don’t leave PT handling to chance. Create written procedures covering:
- Who is responsible for receiving, logging, and distributing PT samples
- How PT samples are identified and labeled in your lab
- Testing requirements (routine procedures, no special treatment)
- Quality control requirements during PT testing
- Result review and verification process
- Submission deadlines and responsibilities
Make it foolproof. Anyone on staff should be able to follow the protocol without confusion.
Step 2: Treat PT Samples Like Patient Samples (Exactly)
Test PT samples using your routine methods, routine equipment, routine reagents, and routine staff. Don’t run extra QC. Don’t use special calibration. Don’t assign them to your most experienced tech.
Why this matters: If you pass PT using special procedures, you’re not proving your routine testing is accurate. And if you fail while using special procedures, CLIA assumes your routine testing is worse.
Step 3: Create a PT Sample Tracking System
Use a log or electronic system to track:
Common mistakes:
- Date PT samples received
- Who received them
- Storage location and temperature
- Testing assignment (who will test which analyte)
- Testing date and time
- Results obtained
- Who reviewed results
- Submission date
This creates accountability and ensures nothing gets missed or delayed.
Step 4: Build In Result Review
Before submitting PT results, implement a two-person verification process:
First review: The testing technologist reviews their own results for obvious errors (decimal points, units, transpositions).
Second review: A second qualified person (supervisor, medical director, or another technologist) independently reviews results before submission.
This catches transcription errors before they become PT failures.
Step 5: Compare to Expected Ranges
Before submitting, ask: “Does this result make clinical sense?”
If your PT glucose result is 850 mg/dL, that’s critically high. If your instrument, reagents, and QC are all performing normally, this result should trigger a second look.
Use your clinical judgment. Unusual results deserve investigation before submission.
Step 6: Submit Early
Don’t wait until the deadline. Submit PT results as soon as you’ve completed testing and verification.
- Reduces risk of missing the deadline
- Allows time to contact PT provider if you have questions
- Removes the pressure of last-minute submission
Set an internal deadline at least one week before the PT provider’s deadline.
Step 7: Review Results When They Arrive
When PT results come back, don’t just file them. Review them even when you pass.
Look for:
- Results near the edge of acceptable range (suggests potential drift)
- Consistent bias in one direction (all results slightly high or low)
- Variability between duplicate samples
- Patterns across multiple PT events
Passing PT doesn’t mean your testing is perfect. It means you’re within acceptable limits. Look for opportunities to improve.
Step 8: Investigate Near-Misses
If you pass PT but results are close to failing, investigate as if you failed.
Why this matters: Near misses often indicate problems that will cause failures in future PT events.
Better to identify and fix issues when you’ve passed than to wait for an actual failure.
- Results near the edge of acceptable range (suggests potential drift)
- Consistent bias in one direction (all results slightly high or low)
- Variability between duplicate samples
- Patterns across multiple PT events
Passing PT doesn’t mean your testing is perfect. It means you’re within acceptable limits. Look for opportunities to improve.
What to Do When PT Fails (The Step-by-Step Response)
Despite your best efforts, PT failures can still occur. Here’s your action plan:
Day 1: Immediate Actions
Stop and assess. Don’t panic, but don’t ignore it either. Determine immediately whether you need to stop patient testing for the failed analyte.
Notify key personnel. Laboratory director, quality manager, and relevant supervisors must know immediately.
Secure evidence. Preserve the PT sample (if available), reagents used, QC records, calibration records, and instrument maintenance logs.
Days 1-7: Investigation
Retest the PT sample if your provider allows it and you still have sample available.
Review all records from the day you tested PT. QC, calibration, maintenance, any unusual occurrences.
Interview the testing technologist. What do they remember about testing this sample? Was anything unusual?
Look for patterns. Has this analyte been problematic before? Have there been patient result complaints?
Identify root cause. Use structured problem-solving (fishbone diagrams, 5 Whys analysis) to get to the real issue.
Days 7-14: Corrective Action
Implement immediate fix. Repair equipment, replace reagent, retrain staff, update procedures.
Implement preventive measures. What can you change to prevent this from happening again?
Verify effectiveness. Run additional QC, test known samples, monitor patient results.
Document everything. Create a complete written record of investigation and corrective action.
Days 14-30: Monitoring
Watch for recurrence. Monitor the analyte closely. Run extra QC if needed.
Review related testing. If the PT failure suggests a broader problem, investigate related analytes or methods.
Prepare for inspection. Assume CLIA surveyors will review this PT failure during your next inspection. Your documentation must tell a complete, convincing story.
Preparing for the Inspector’s Questions
When CLIA surveyors visit after a PT failure, they’ll ask pointed questions. Here’s what to expect and how to prepare:
“Show me your PT failure investigation.”
You should be able to produce a complete written record including failure, investigation, root cause, corrective action, and verification of effectiveness.
“How did you verify your corrective action worked?”
Have specific evidence (QC data, retest results, monitoring records) showing the problem is fixed.
“Did you review patient results that might have been affected?”
If the PT failure could have impacted patient testing, you should have reviewed relevant patient results and acted if needed.
“What did you change to prevent this from happening again?”
Describe specific, concrete preventive measures, not vague promises to “be more careful.”
“How do you know this is an isolated incident and not a systemic problem?”
Show evidence (historical QC data, previous PT results, ongoing monitoring) proving your testing is normally reliable.
Your Next Step: Audit Your PT Program
PT failures are preventable. But prevention requires intentional systems, not just competent staff.
Here’s what you can do this week:
Review your last three PT events. Did you pass everything? Were any results close to failing? Are there patterns or trends?
Review your last three PT events. Did you pass everything? Were any results close to failing? Are there patterns or trends?
“Did you review patient results that might have been affected?”
If the PT failure could have impacted patient testing, you should have reviewed relevant patient results and acted if needed.
“What did you change to prevent this from happening again?”
Describe specific, concrete preventive measures, not vague promises to “be more careful.”
“How do you know this is an isolated incident and not a systemic problem?”
Show evidence (historical QC data, previous PT results, ongoing monitoring) proving your testing is normally reliable.
Why Smart Labs Still Fail PT
PT failures happen to good laboratories with competent staff and well-maintained equipment. Here’s why:
1. Treating PT Samples Differently Than Patient Samples
Some labs unconsciously give PT samples “special treatment,” like running extra quality control, using different reagent lots, or having the most experienced tech perform the testing.
The problem: This violates CLIA’s requirement to test PT samples using routine procedures. If you fail PT while using special procedures, CLIA knows your routine testing is even worse.
The fix: Treat PT samples exactly like patient samples. Same workflow, same techs, same procedures.
2. Not Reading PT Instructions Carefully
PT providers include specific instructions with each shipment. Not reading them carefully causes failures.
Common mistakes:
Reputational Damage
Even if CLIA doesn’t sanction you heavily, PT failures damage relationships with ordering physicians, hospitals, and patients. In competitive markets, word spreads quickly.
Bottom line: Prevention is far cheaper than remediation.
